MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 151 filers reported holding MACROGENICS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $113,035 | +99.5% | 11,750 | -3.4% | 0.00% | +100.0% |
| Q3 2023 | $56,656 | -7.1% | 12,158 | +6.6% | 0.00% | 0.0% |
| Q2 2023 | $61,000 | -25.4% | 11,402 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $81,752 | +106071.4% | 11,402 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $77 | -99.8% | 11,402 | -9.2% | 0.00% | +50.0% |
| Q3 2022 | $43,000 | +16.2% | 12,562 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $37,000 | -83.8% | 12,562 | +15.2% | 0.00% | -75.0% |
| Q3 2021 | $228,000 | -32.1% | 10,909 | -12.8% | 0.01% | -33.3% |
| Q2 2021 | $336,000 | -7.7% | 12,512 | +9.5% | 0.01% | -14.3% |
| Q1 2021 | $364,000 | +47.4% | 11,429 | +5.6% | 0.01% | +40.0% |
| Q4 2020 | $247,000 | -9.5% | 10,821 | 0.0% | 0.01% | -23.1% |
| Q3 2020 | $273,000 | -11.1% | 10,821 | -1.5% | 0.01% | -18.8% |
| Q2 2020 | $307,000 | – | 10,986 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
| DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
| BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
| TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
| Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
| Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
| First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |